Fidelity SPDR Advertisement
Home > Boards > Free Zone > Penny Trading - Technical > MOMO'S BREAKOUT BOARD

.48 x .49 XCLL

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
VIDAO Member Profile
 
Followed By 264
Posts 11,184
Boards Moderated 0
Alias Born 02/21/08
160x600 placeholder
Roche Hit By Failure Of Cancer Drug Trial
Roche said a late-stage study of its breast cancer drug Kadcyla failed to yield superior results to an existing treatment, damaging the outlook for stronger sales in one of its key drug markets.
More Top Equities Stories Of The Day
Deezer Names New CEO Before Full U.S. Launch
Whistleblowers Score a Big Payday -- Update
Mobile's Rise Poses a Riddle for Banks
AT&T Boosts Dividend
U.S. Hot Stocks: Hot Stocks to Watch
Brazilian Shares Rise, Led by Rossi Residencial; Real Weakens Slightly
Oracle Beats Street View for First Time in a Year
Alstom CEO Expects to Settle DOJ Bribery Allegations Very Soon
VIDAO   Tuesday, 05/01/12 10:52:15 AM
Re: None
Post # of 1471645 
.48 x .49 XCLL

I posted this in hopes that it helps someone decide what to do in this stock. So therefore they may purchase the stock and increase the PPS
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist